Pharmacy Benefit Management Acquisition

Client Type: Private Company

We served as lead healthcare regulatory counsel, as well as provided antitrust, employee benefits and tax support, for a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary (PBM) of a leading pharmacy healthcare provider.

You Also May Be Interested In:

Pharos Capital’s Charter Health Acquires St. Luke’s Home Hospice LLC and Arizona Select Hospice LLC

We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...

Client Type: Private Company
Representation of Life Sciences Company Fagron Holding USA LLC

Representation of Life Sciences Company Fagron Holding USA LLC

We served as lead counsel representing a national pharmaceutical ingredient supplier and its wholly-owned subsidiaries in an investigation of alleged...

Client Type: Private Company
axialHealthcare Closes Series C Funding Round

Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...

Client Type: Private Company